The European AI in antibody generation market is experiencing a considerable surge, driven primarily by rising investments in biotechnology and a greater focus on personalized medicine. Researchers predict remarkable advancements in medicinal antibody development utilizing artificial intelligence, particularly within sectors like oncology and immun